World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
93
Citations
40946
World Ranking
668
National Ranking
18

David L. Vaux publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where David L. Vaux sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 211 publications — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

David L. Vaux D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where David L. Vaux sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 93 D-Index — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

David L. Vaux is a researcher affiliated with the Walter and Eliza Hall Institute of Medical Research in Australia. Their scholarly work centers predominantly on biochemistry, genetics, and molecular biology, with additional focus areas in medicine. A significant portion of their research is situated within subfields such as molecular biology, epidemiology, oncology, genetics, and computational theory and mathematics.

The primary topics that characterize their studies include:

  • Cell death mechanisms and regulation
  • RNA interference and gene delivery
  • CRISPR and genetic engineering
  • Pluripotent stem cells research
  • Virus-based gene therapy research
  • Autophagy in disease and therapy
  • PARP inhibition in cancer therapy

David L. Vaux has contributed to several research papers published in notable venues. These include:

  • "Cell Death in the Origin and Treatment of Cancer," 2020, Molecular Cell
  • "Targeting triple-negative breast cancers with the Smac-mimetic birinapant," 2020, Cell Death and Differentiation
  • "Glucocorticoids can induce BIM to trigger apoptosis in the absence of BAX and BAK1," 2020, Cell Death and Disease
  • "The BCL-2 protein family: from discovery to drug development," 2025, Cell Death and Differentiation
  • "Easy Multiple Sequential CRISPR/Cas9 Knockouts in Cell Lines Using a Cre/LoxP Re-Cyclable Vector," 2021, Research Square (Research Square)

Their collaborative network includes frequent co-authors such as Andreas Strasser, Nima Etemadi, Dong Li, Margaret C. Cummings, and Ruth M. Kluck.

David L. Vaux's research outputs frequently appear in prominent scientific journals, with multiple publications in Cell Death and Differentiation, and additional works in Molecular Cell, Cell Death and Disease, Research Square, and bioRxiv.

Best Publications

  • Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.

    David L. Vaux;Suzanne Cory;Jerry M. Adams

  • Identification of DIABLO, a Mammalian Protein that Promotes Apoptosis by Binding to and Antagonizing IAP Proteins

    Anne M Verhagen;Paul G Ekert;Paul G Ekert;Miha Pakusch;John Silke

  • CELL DEATH IN DEVELOPMENT

    David L Vaux;Stanley J Korsmeyer

  • The molecular biology of apoptosis.

    D L Vaux;A Strasser

  • IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis

    James E. Vince;W. Wei-Lynn Wong;Nufail Khan;Rebecca Feltham

  • Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease

    Andreas Strasser;Senga Whittingham;David L. Vaux;Mary L. Bath

  • Error bars in experimental biology

    Geoffrey David. Cumming;Fiona Margaret. Fidler;David. Vaux

  • An evolutionary perspective on apoptosis.

    David L. Vaux;Georg Haecker;Andreas Strasser

  • Toward an understanding of the molecular mechanisms of physiological cell death.

    David L. Vaux

  • Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2

    David L. Vaux;Irving L. Weissman;Stuart K. Kim

  • HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins.

    Anne M Verhagen;John Silke;Paul G Ekert;Paul G Ekert;Miha Pakusch

  • IAPs, RINGs and ubiquitylation

    David L. Vaux;John Silke

  • Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies

    Alex R. D. Delbridge;Stephanie Grabow;Andreas Strasser;David L. Vaux

  • Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome

    Vanessa S. Marsden;Liam O'Connor;Liam O'Connor;Lorraine A. O'Reilly;John Silke

  • Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype

    Anthony G. Uren;Lee Lee Wong;Miha Pakusch;Kerry J. Fowler

  • Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors.

    Anthony G. Uren;Miha Pakusch;Christine J. Hawkins;Kirsten L. Puls

  • RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL

    Kate E. Lawlor;Nufail Khan;Alison Mildenhall;Motti Gerlic

  • RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis.

    James A Rickard;James A Rickard;Joanne A O'Donnell;Joanne A O'Donnell;Joseph M Evans;Joseph M Evans;Najoua Lalaoui;Najoua Lalaoui

  • Inhibitor of apoptosis proteins and their relatives: IAPs and other BIRPs.

    Anne M Verhagen;Elizabeth J Coulson;David L Vaux

  • Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts.

    Janette Allison;Harry M. Georgiou;Andreas Strasser;David L. Vaux

Frequent Co-Authors

John Silke
John Silke Walter and Eliza Hall Institute of Medical Research
Paul G Ekert
Paul G Ekert University of New South Wales
James E. Vince
James E. Vince Walter and Eliza Hall Institute of Medical Research
Andreas Strasser
Andreas Strasser Walter and Eliza Hall Institute of Medical Research
Kate E. Lawlor
Kate E. Lawlor Hudson Institute of Medical Research
James M. Murphy
James M. Murphy Walter and Eliza Hall Institute of Medical Research
Warren S. Alexander
Warren S. Alexander Walter and Eliza Hall Institute of Medical Research
Jerry M. Adams
Jerry M. Adams Walter and Eliza Hall Institute of Medical Research
Lorraine A. O'Reilly
Lorraine A. O'Reilly Walter and Eliza Hall Institute of Medical Research
Suzanne Cory
Suzanne Cory Walter and Eliza Hall Institute of Medical Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As you explore a future in Molecular Biology, it’s important to consider how online degrees and bridge programs can expand your career options. Many students interested in biomedical sciences transition into health care, nursing, and research-focused roles that offer flexibility and growth.

For example, those who hold an associate degree in nursing (ADN) might consider adn to fnp programs, which lead to advanced practice as Family Nurse Practitioners. If you’re seeking accelerated options and you’re not already a nurse, there are online direct entry msn programs for non-nurses that allow you to leverage a science background into a nursing career.

Choosing the right institution matters, especially in online learning. Deciding between capella university vs wgu rn to bsn can help you find a program that fits your schedule and budget. If you already hold a bachelor’s degree in nursing, rn to msn bridge programs offer an affordable path to advanced roles in healthcare leadership or research.

Exploring these interconnected pathways can help you align your molecular biology education with evolving healthcare careers.

Best Scientists Citing David L. Vaux

Trending Scientists

Recently Published Articles